BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 13, Issue 33
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (599)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF13
HTML116
Figures (1-1)15
Tables (1-1)11
 Sum=155
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse83
Download243
 Sum=326
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse30
Download61
 Sum=91
Nov 26, 2025 (publication date) through Jan 9, 2026
Times Cited of This Article
  • Times Cited  (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report
Copyright ©The Author(s) 2025.
World J Clin Cases. Nov 26, 2025; 13(33): 112305
Published online Nov 26, 2025. doi: 10.12998/wjcc.v13.i33.112305
Table 1 Measurement of factor VIII activity at key clinical time points
Time point
FVIII activity result
Clinical significance
At diagnosis (upon readmission)< 1% (reference range: 60%–150%)Confirmed the diagnosis of acquired hemophilia A
End of therapy (follow-up)188.2%Confirmed complete remission, indicating successful treatment and cure
FVIII: Factor VIII.
Full Size Table
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345